Abstract:New drug development is an extremely time-consuming and high-risk process. [1]It has been widely valued by the biomedical industry to fully explore the new uses of existing drugs and reorientate them. [2]How to find drug disease with potential therapeutic relationship from a large number of unproven relationship pairs is the research focus of drug reorientation. With the help of machine learning model, we can improve the enrichment degree of potential drug disease relationship pairs, and reduce the false positive rate of prediction. In the past few years, a series of graph based convolutional network models have been developed to calculate the information latent feature representation of nodes and links. Researchers at home and abroad have done a lot of research on network embedding technology based on biomedical data, and have achieved a series of important research results. Among them, the research methods used can be divided into two categories: one is the traditional machine learning algorithm based on artificial feature extraction, the other is the method based on deep learning. For example, kipf and welling [3]proposed a new graph convolution network (GCN) with parts of existing models, DeepDR [4] and DTINet [5] based on node characteristics and their connections, which can be used for node classification. Aiming at the problem of imbalance of drug information data samples, the invention provides a drug relocation method based on deep learning multi-source heterogeneous network. In order to avoid the limitations of traditional feature extraction methods, such as highly dependent on the experience and knowledge of medical staff, strong subjectivity, consuming a lot of time and energy to complete, and extracting high-quality features with distinguishing features often exists In this paper, with the help of graph convolution encoder model and variational auto encoder neural network, we can automatically learn the characteristics of multi-source and heterogeneous drug low-dimensional network, and complete the drug relocation of drug disease association prediction.

An Enhanced LRMC Method for Drug Repositioning Via GCN-based HIN Embedding

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks

Drug repositioning with adaptive graph convolutional networks

Enhancing Drug Repositioning through Local Interactive Learning with Bilinear Attention Networks

A computational drug repositioning model based on hybrid similarity side information powered graph neural network

Drug repositioning based on weighted local information augmented graph neural network

Computational Drug Repositioning with Random Walk on a Heterogeneous Network

Hybrid Attentional Memory Network for Computational drug repositioning

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

Drug Repositioning Method Based on Deep Neural Network

A weighted bilinear neural collaborative filtering approach for drug repositioning

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

Empowering Graph Neural Network-Based Computational Drug Repositioning with Large Language Model-Inferred Knowledge Representation

A Drug Information Embedding Method Based on Graph Convolution Neural Network.

A geometric deep learning framework for drug repositioning over heterogeneous information networks

DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

A Fused Deep Learning Approach to Transform Novel Drug Repositioning

A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning